ABVC BioPharma, Inc. Restricted Cash and Cash Equivalents
ABVC BioPharma, Inc. (ABVC) had Restricted Cash and Cash Equivalents of $642.90 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2023-08-14
- 2023-06-30: Restricted Cash and Cash Equivalents $642.90K.
- 2023-03-31: Restricted Cash and Cash Equivalents $656.92K.
- 2022-12-31: Restricted Cash and Cash Equivalents $1.31M.
- 2022-09-30: Restricted Cash and Cash Equivalents $646.60K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2023-06-30 | $642.90K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $656.92K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.31M 10-Q · filed 2023-08-14 |
| 2022-09-30 | $646.60K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $688.63K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $714.65K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $736.67K 10-K · filed 2023-03-31 |
| 2021-09-30 | $734.16K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $732.16K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $718.16K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $728.16K 10-K · filed 2022-03-31 |
| 2020-09-30 | $16.15K 10-Q · filed 2020-11-17 |
| 2020-06-30 | $16.15K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $16.15K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $16.15K 10-K · filed 2021-03-16 |
| 2019-09-30 | $16.12K 10-Q · filed 2019-11-18 |
| 2019-06-30 | $16.12K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $16.09K 10-Q · filed 2019-05-28 |
| 2018-12-31 | $16.09K 10-K · filed 2020-05-15 |